4p83

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (12:22, 20 December 2023) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 1: Line 1:
 +
==Structure of engineered PyrR protein (PURPLE PyrR)==
==Structure of engineered PyrR protein (PURPLE PyrR)==
-
<StructureSection load='4p83' size='340' side='right' caption='[[4p83]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
+
<StructureSection load='4p83' size='340' side='right'caption='[[4p83]], [[Resolution|resolution]] 2.50&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4p83]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P83 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4P83 FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4p83]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4P83 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4P83 FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=U5P:URIDINE-5-MONOPHOSPHATE'>U5P</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.5&#8491;</td></tr>
-
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4p80|4p80]], [[4p81|4p81]], [[4p82|4p82]], [[4p84|4p84]], [[4p86|4p86]]</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=U5P:URIDINE-5-MONOPHOSPHATE'>U5P</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4p83 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p83 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4p83 RCSB], [http://www.ebi.ac.uk/pdbsum/4p83 PDBsum]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4p83 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4p83 OCA], [https://pdbe.org/4p83 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4p83 RCSB], [https://www.ebi.ac.uk/pdbsum/4p83 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4p83 ProSAT]</span></td></tr>
</table>
</table>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
Evolution and design of protein complexes are almost always viewed through the lens of amino acid mutations at protein interfaces. We showed previously that residues not involved in the physical interaction between proteins make important contributions to oligomerization by acting indirectly or allosterically. In this work, we sought to investigate the mechanism by which allosteric mutations act, using the example of the PyrR family of pyrimidine operon attenuators. In this family, a perfectly sequence-conserved helix that forms a tetrameric interface is exposed as solvent-accessible surface in dimeric orthologs. This means that mutations must be acting from a distance to destabilize the interface. We identified 11 key mutations controlling oligomeric state, all distant from the interfaces and outside ligand-binding pockets. Finally, we show that the key mutations introduce conformational changes equivalent to the conformational shift between the free versus nucleotide-bound conformations of the proteins.
 +
 +
Evolution of oligomeric state through allosteric pathways that mimic ligand binding.,Perica T, Kondo Y, Tiwari SP, McLaughlin SH, Kemplen KR, Zhang X, Steward A, Reuter N, Clarke J, Teichmann SA Science. 2014 Dec 19;346(6216):1254346. doi: 10.1126/science.1254346. PMID:25525255<ref>PMID:25525255</ref>
 +
 +
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
 +
</div>
 +
<div class="pdbe-citations 4p83" style="background-color:#fffaf0;"></div>
 +
== References ==
 +
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Clarke, J]]
+
[[Category: Large Structures]]
-
[[Category: Kondo, Y]]
+
[[Category: Synthetic construct]]
-
[[Category: McLaughlin, S]]
+
[[Category: Clarke J]]
-
[[Category: Perica, T]]
+
[[Category: Kondo Y]]
-
[[Category: Reuter, N]]
+
[[Category: McLaughlin S]]
-
[[Category: Steward, A]]
+
[[Category: Perica T]]
-
[[Category: Teichmann, S A]]
+
[[Category: Reuter N]]
-
[[Category: Tiwari, S]]
+
[[Category: Steward A]]
-
[[Category: Reconstructed amino acid sequence]]
+
[[Category: Teichmann SA]]
-
[[Category: Rna binding protein]]
+
[[Category: Tiwari S]]
-
[[Category: Transcription]]
+

Current revision

Structure of engineered PyrR protein (PURPLE PyrR)

PDB ID 4p83

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools